Logo
E

Enable Medicine

0 employees

At Enable Medicine, we index biological data into highly detailed maps of human disease. This atlas is utilized to guide novel drug target discovery, identify biomarkers of therapeutic response, and develop optimal treatment strategies. Our lab in Menlo Park, California, generates high-parameter biological datasets, and our cloud-based operating system allows researchers to organize, process, query, and analyze this data at scale. Taken together, our platform unlocks the ability to search biology, where complex questions about human disease can be asked and answered for the first time. We build and provide these capabilities to our network of leading academic institutions and pharmaceutical companies around the world. Our collaborative research spans numerous indications, with a core focus on unmet needs in oncology and autoimmune diseases. We advance science by accelerating data generation, methods development, research insights, and high-impact publications. Our interdisciplinary team of scientists, engineers, researchers, and investors focuses on decoding biological systems to make drug discovery, development, and patient care more deterministic. Come join us on our mission to decipher biology and meaningfully improve the way patients are treated.

Investor insights

Funding rounds participated in

$60M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2019

Funding rounds raised

Total raised

$60M

from 3 investors over 1 rounds

E

Enable Medicine raised $60M on May 7, 2022

Investors: Anthos Capital, General Catalyst and + 4 Other investors

FAQ